SIGLEC1 and neoplasm: recently confirmed that microglial genes (CX3CR1, TMEM119, and P2RY12) were mainly expressed in the periphery, while activated macrophage genes (TNF, CCL2, LYZ, CCR2, CXCR4, and SIGLEC1) were predominantly detected within the core tumor regions (74).